ABSTRACT
Purpose To control the therapeutic results in manual-dynamic physiotherapy for clubfeet we analyzed the gait pattern in children with clubfeet and their healthy twin siblings, aged between 3 and 13 years for GaitUp and 4 to 14 years for the footplate V9.
Methods With the inertial GaitUp sensors and the footscan V9 pedobarographic plate the 11 twin-pairs were tested and statistically assessed. For the GaitUp sensors 22 parameters were considered and 10 parameters for the footplate V9. We analyzed the gait pattern for each child separately for both feet and in a second evaluation compared the affected feet with the ipsilateral feet of the healthy twins. The statistical comparisons were made with nonparametric methods. An additional twin girl treated with various therapies and her sister are included as a contrast.
Results Especially in younger children, the gait pattern is not stabilized yet. Therefore, sometimes the healthy twins have inferior values in gait patterns than the affected siblings. Over the whole study there are only minor statistical differences between the affected group and the healthy group suggesting that with the manual-dynamic therapy the clubfeet children show a gait pattern statistically similar to the healthy group. Noteworthy are the less convincing results of the contrast twin.
Conclusion Manual-dynamic physiotherapy can lead to a gait pattern equal to the one of unaffected children the same age. Our results do not support the statement that in one-sided clubfoot the other foot cannot be considered normal.
IMPLICATIONS FOR REHABILITATION
Clubfeet are a disabling birth defect affecting 1 to 3 babies per 1000 births.
The manual-dynamic physiotherapy for clubfeet starting at birth leads to a normal gait pattern.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Zurich, Switzerland, Number 2023-00290. ClinicalTrials ID: NCT05913934.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data are with the authors and are available anonymized upon reasonable request
